Sun Pharma Gets FDA Warning After Inspection of Facility

  • FDA withholds future approvals from company's Halol Facility
  • Company working on completing its remediation process

Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, has received a warning letter from the U.S. Food and Drug Administration following an inspection at one of its facilities.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.